FDA Brief

Warning letters Drugs

FDA warning letter to

Gordon Laboratories Inc.

High riskIssued Aug 17, 2022Posted Aug 30, 2022Division of Pharmaceutical Quality Operations IV

FDA: Gordon Laboratories' artnaturals hand sanitizer held benzene and acetaldehyde impurities, and CGMP failures let them happen.

What happened

FDA laboratory testing of artnaturals SCENT FREE HAND SANITIZER in U.S. distribution found benzene at about 15 ppm, acetaldehyde at about 146 ppm, and acetal at about 469 ppm. FDA publicized the results in October 2021, the company recalled two batches that month and expanded the recall to at least 38 more batches in April 2022, and then FDA inspected the Carson, California plant from February 8 to March 10, 2022. The inspection found the company never properly investigated the impurity source, did not test incoming ingredients, and ran an unvalidated water system with uninvestigated microbial failures.

What FDA found

  1. The company did not thoroughly investigate why its hand sanitizer batches failed on benzene, acetal and acetaldehyde, did not check whether other batches were affected, and its written response gave no evidence for its proposed root cause.

    21 CFR 211.192
  2. The company did not investigate repeated microbiological results from its water system that went over its own action limits, and had no water testing data before July 2021.

    21 CFR 211.192
  3. The company used incoming ingredients without testing them, took a carbomer lot from an unapproved supplier, took another lot with no certificate of analysis, and relied on supplier certificates without checking their reliability.

    21 CFR 211.84(d)(1) and 211.84(d)(2)
  4. The company used water in its drugs without ever validating the water system, and its sampling did not check for Burkholderia Cepacia Complex, a group of bacteria that can harm people.

    21 CFR 211.100(a)
  5. Given the known benzene risk, the company had no finished-product specification for benzene in its hand sanitizers.

    21 CFR 211.160(b)

What FDA wants

FDA tells the company to reply in writing within 15 working days describing the corrections, including an independent assessment of its investigation system, all water system results plus a remediation and validation plan, and impurity results for every hand sanitizer batch released. FDA also recommends hiring a qualified CGMP consultant to audit the whole operation.

Who should pay attention

  • brands that hire contract manufacturers to make their hand sanitizers or other OTC drugs
  • manufacturers that accept supplier certificates of analysis instead of testing each ingredient lot
  • drugmakers with in-house or aging water systems used in production

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Owen Biosciences, Inc.

    Owen Biosciences' over-the-counter benzoyl peroxide acne lotion had over 20 parts per million benzene and lacked release testing.

    High risk
  2. Accra-Pac, Inc. dba Voyant Beauty

    Voyant Beauty's Elkhart, Indiana plant made OTC aerosol drugs contaminated with benzene and failed to investigate or test properly.

    High risk
  3. Virgin Scent Inc. dba Artnaturals

    FDA warns Artnaturals after hand sanitizer tests found benzene and acetaldehyde impurities and inspection found CGMP failures.

    High risk
  4. Mirfeel Korea Co., Ltd.

    Mirfeel Korea's hand sanitizer contained benzene and had testing failures; FDA also says food-pouch packaging misbranded.

    High risk